EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PARP7 inhibits type I interferon signaling to prevent autoimmunity and lung disease

Devon Jeltema iD, Kennady Knox iD, Nicole Dobbs iD, Zhen Tang iD, Cong Xing iD, Antonina Araskiewicz iD, Kun Yang iD, Ivan Rodriguez Siordia iD, Jason Matthews iD, Michael Cohen iD, Nan Yan iD

Journal of Experimental Medicine · 05.05.2025 · 222 (5)

DOI: 10.1084/jem.20241184 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 19.02.2025. Verfasst von Devon Jeltema und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, USA. Hauptthemen laut MEDLINE: Autoimmunity, Interferon Type I, Signal Transduction, Poly(ADP-ribose) Polymerases. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Texas Southwestern, NIAID NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type I IFN (IFN-I) induce hundreds of antiviral genes as well as negative regulators that limit IFN-I signaling. Here, we investigate the family of 16 PARPs and find that 11 PARPs are ISGs, of which 8 PARPs inhibit IFN-I production. PARP7 is the most potent negative feedback regulator of IFN-I production. Using Parp7−/− and Parp7H532A/H532A mice, we show that PARP7 loss leads to systemic autoimmunity characterized by splenomegaly and increased autoantibodies and inflammatory cytokines. PARP7 loss also results in perivascular immune infiltration in the lung that forms tertiary lymphoid structures. Mechanistically, PARP7 inhibits multiple innate immune pathways in a cell-intrinsic and MARylation-dependent manner. PARP7 interacts with IRF3 through the catalytic domain and disrupts the IRF3:CBP/p300 transcriptional holocomplex required for IFN-I production. Irf3−/− or Irf3S1/S1 (transcription defective) or Sting−/− rescues Parp7H532A/H532A mouse autoimmunity and lung disease. Together, our study reveals physiological functions of PARP7 as a negative feedback regulator of IFN-I production that maintains immune homeostasis particularly in the lung.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutoimmunityInterferon Type ISignal TransductionPoly(ADP-ribose) PolymerasesLung DiseasesAnimalsMiceInterferon Regulatory Factor-3HumansMice, KnockoutMice, Inbred C57BLImmunity, InnateAutoantibodies

Substanzen

Interferon Type IPoly(ADP-ribose) PolymerasesInterferon Regulatory Factor-3Irf3 protein, mouseAutoantibodies

Autor:innen und Institutionen

  • Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Department of Chemical Physiology and Biochemistry, Oregon Health and Science University, Portland, OR, USA.
  • Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.

ORCID-Profile: Devon Jeltema, Kennady Knox, Nicole Dobbs, Zhen Tang, Cong Xing, Antonina Araskiewicz, Kun Yang, Ivan Rodriguez Siordia, Jason Matthews, Michael Cohen, Nan Yan

Förderung

  • University of Texas Southwestern
  • NIAID NIH HHS
  • NCI NIH HHS
  • NIH HHS
  • Lupus Research Alliance
  • National Cancer Institute
  • National Institutes of Health

Zitieren

APA

Jeltema, D., Knox, K., Dobbs, N., Tang, Z., Xing, C., Araskiewicz, A., Yang, K., Siordia, I. R., Matthews, J., Cohen, M., & Yan, N. (2025). PARP7 inhibits type I interferon signaling to prevent autoimmunity and lung disease. Journal of Experimental Medicine, 222(5). https://doi.org/10.1084/jem.20241184

Vancouver

Jeltema D, Knox K, Dobbs N, Tang Z, Xing C, Araskiewicz A, et al. PARP7 inhibits type I interferon signaling to prevent autoimmunity and lung disease. Journal of Experimental Medicine. 2025;222(5). doi:10.1084/jem.20241184

BibTeX
@article{Jeltema2025,
  author = {Jeltema, Devon and Knox, Kennady and Dobbs, Nicole and Tang, Zhen and Xing, Cong and Araskiewicz, Antonina and Yang, Kun and Siordia, Ivan Rodriguez and Matthews, Jason and Cohen, Michael and Yan, Nan},
  title = {PARP7 inhibits type I interferon signaling to prevent autoimmunity and lung disease},
  journal = {Journal of Experimental Medicine},
  year = {2025},
  volume = {222},
  number = {5},
  doi = {10.1084/jem.20241184}
}
Kostenlos starten →